Greenyn Biotechnology , Ltd Profit Margin

As of the most recent data (June 2026), 6846.TWO shows a profit margin of 14.67%. That compares with 15.98% in the prior-year period — down 8.2% year over year. That is above the Healthcare sector average of 10.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6846.TWO's profit margin is now 14.67% (was 15.98%) — a 8.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Greenyn Biotechnology , Ltd is outperforming or lagging.

The Healthcare sector average profit margin is about 10.58%. Greenyn Biotechnology , Ltd is at 14.67%, which is higher that average. That is roughly 38.6% above the sector mean. Use the comparison chart on this page to see how 6846.TWO stacks up against individual peers as well.

That compares with 15.98% in the prior-year period — down 8.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Greenyn Biotechnology , Ltd with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Greenyn Biotechnology , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 14.67%) with ownership activity and broader fundamentals.